NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial ...
NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial ...
Stay updated with breaking news from Intangible Assets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial ...
DALLAS, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled financial services holding company that provides liquidity and related trust and custody services to
Issues 2024 Guidance with Improved Profit Growth and Declares Quarterly Dividend ...
Beneficient (Nasdaq: BENF) today reported its financial results for the fiscal 2024 third quarter ended December 31, 2023....
Further Developed GP Solutions Program, Launched New Products/Service and Improved Operational Efficiencies and Financial PositionDALLAS, Feb. 13, 2024 -- Beneficient , a technology-enabled...